BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 31289104)

  • 1. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
    Kawamura Y; Nakaoka H; Nakayama A; Okada Y; Yamamoto K; Higashino T; Sakiyama M; Shimizu T; Ooyama H; Ooyama K; Nagase M; Hidaka Y; Shirahama Y; Hosomichi K; Nishida Y; Shimoshikiryo I; Hishida A; Katsuura-Kamano S; Shimizu S; Kawaguchi M; Uemura H; Ibusuki R; Hara M; Naito M; Takao M; Nakajima M; Iwasawa S; Nakashima H; Ohnaka K; Nakamura T; Stiburkova B; Merriman TR; Nakatochi M; Ichihara S; Yokota M; Takada T; Saitoh T; Kamatani Y; Takahashi A; Arisawa K; Takezaki T; Tanaka K; Wakai K; Kubo M; Hosoya T; Ichida K; Inoue I; Shinomiya N; Matsuo H
    Ann Rheum Dis; 2019 Oct; 78(10):1430-1437. PubMed ID: 31289104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank.
    Sandoval-Plata G; Morgan K; Abhishek A
    Ann Rheum Dis; 2021 Sep; 80(9):1220-1226. PubMed ID: 33832965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-specific gout susceptibility loci and enrichment of selection pressure on
    Nakayama A; Nakatochi M; Kawamura Y; Yamamoto K; Nakaoka H; Shimizu S; Higashino T; Koyama T; Hishida A; Kuriki K; Watanabe M; Shimizu T; Ooyama K; Ooyama H; Nagase M; Hidaka Y; Matsui D; Tamura T; Nishiyama T; Shimanoe C; Katsuura-Kamano S; Takashima N; Shirai Y; Kawaguchi M; Takao M; Sugiyama R; Takada Y; Nakamura T; Nakashima H; Tsunoda M; Danjoh I; Hozawa A; Hosomichi K; Toyoda Y; Kubota Y; Takada T; Suzuki H; Stiburkova B; Major TJ; Merriman TR; Kuriyama N; Mikami H; Takezaki T; Matsuo K; Suzuki S; Hosoya T; Kamatani Y; Kubo M; Ichida K; Wakai K; Inoue I; Okada Y; Shinomiya N; Matsuo H;
    Ann Rheum Dis; 2020 May; 79(5):657-665. PubMed ID: 32238385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.
    Matsuo H; Yamamoto K; Nakaoka H; Nakayama A; Sakiyama M; Chiba T; Takahashi A; Nakamura T; Nakashima H; Takada Y; Danjoh I; Shimizu S; Abe J; Kawamura Y; Terashige S; Ogata H; Tatsukawa S; Yin G; Okada R; Morita E; Naito M; Tokumasu A; Onoue H; Iwaya K; Ito T; Takada T; Inoue K; Kato Y; Nakamura Y; Sakurai Y; Suzuki H; Kanai Y; Hosoya T; Hamajima N; Inoue I; Kubo M; Ichida K; Ooyama H; Shimizu T; Shinomiya N
    Ann Rheum Dis; 2016 Apr; 75(4):652-9. PubMed ID: 25646370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
    Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
    J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Influences on Hyperuricemia and Gout.
    Merriman T
    Rheum Dis Clin North Am; 2017 Aug; 43(3):389-399. PubMed ID: 28711141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the genetic architecture of hyperuricemia and gout.
    Merriman TR
    Arthritis Res Ther; 2015 Apr; 17(1):98. PubMed ID: 25889045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
    Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
    BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of gout.
    Choi HK; Zhu Y; Mount DB
    Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.
    Jing J; Ekici AB; Sitter T; Eckardt KU; Schaeffner E; Li Y; Kronenberg F; Köttgen A; Schultheiss UT
    Sci Rep; 2018 Sep; 8(1):13184. PubMed ID: 30181573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study.
    Chang YS; Lin CY; Liu TY; Huang CM; Chung CC; Chen YC; Tsai FJ; Chang JG; Chang SJ
    Arthritis Res Ther; 2022 Oct; 24(1):229. PubMed ID: 36221101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The haplotype of
    Yang HJ; Liu M; Kim MJ; Park S
    Int J Food Sci Nutr; 2021 May; 72(3):391-401. PubMed ID: 32806975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
    Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
    Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of hyperuricaemia and gout.
    Merriman TR; Dalbeth N
    Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study.
    Chen CJ; Tseng CC; Yen JH; Chang JG; Chou WC; Chu HW; Chang SJ; Liao WT
    Sci Rep; 2018 Feb; 8(1):3137. PubMed ID: 29453348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of hyperuricaemia and gout.
    Reginato AM; Mount DB; Yang I; Choi HK
    Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
    Dehghan A; Köttgen A; Yang Q; Hwang SJ; Kao WL; Rivadeneira F; Boerwinkle E; Levy D; Hofman A; Astor BC; Benjamin EJ; van Duijn CM; Witteman JC; Coresh J; Fox CS
    Lancet; 2008 Dec; 372(9654):1953-61. PubMed ID: 18834626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.
    Stark K; Reinhard W; Grassl M; Erdmann J; Schunkert H; Illig T; Hengstenberg C
    PLoS One; 2009 Nov; 4(11):e7729. PubMed ID: 19890391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
    Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
    Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.